These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18695170)

  • 21. [Potential risks associated with long-term PPI use].
    Kamiya T
    Nihon Rinsho; 2016 Aug; 74(8):1387-1391. PubMed ID: 30562448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescribing proton pump inhibitors: is it time to pause and rethink?
    Vakil N
    Drugs; 2012 Mar; 72(4):437-45. PubMed ID: 22356286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton pump inhibitor use and the risk of fractures among an older adult cohort.
    Harding BN; Weiss NS; Walker RL; Larson EB; Dublin S
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):596-603. PubMed ID: 29493043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interactions of proton pump inhibitors with oral bisphosphonates and fracture risk].
    Bartl R; von Tresckow E
    Dtsch Med Wochenschr; 2012 Apr; 137(15):804-5. PubMed ID: 22492419
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiovascular Risk of Proton Pump Inhibitors.
    Ariel H; Cooke JP
    Methodist Debakey Cardiovasc J; 2019; 15(3):214-219. PubMed ID: 31687101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton pump inhibitors use; beware of side-effects.
    Asim Syed IA; Abbas Naqvi SH
    J Pak Med Assoc; 2016 Oct; 66(10):1314-1318. PubMed ID: 27686311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitors and fracture: they impair bone quality and increase fall risk?
    Sugiyama T; Watarai K; Oda T; Kim YT; Oda H
    Osteoporos Int; 2016 Apr; 27(4):1675-1676. PubMed ID: 26860500
    [No Abstract]   [Full Text] [Related]  

  • 28. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
    Gyawali CP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):46. PubMed ID: 28780717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Refractory gastroesophageal reflux disease (GERD) and PPI safety].
    Huerta-Iga FM
    Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():1-3. PubMed ID: 24041041
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxicity of long-term use of proton pump inhibitors in children.
    De Bruyne P; Ito S
    Arch Dis Child; 2018 Jan; 103(1):78-82. PubMed ID: 29237614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton Pump Inhibitors: What the Internist Needs to Know.
    Spechler SJ
    Med Clin North Am; 2019 Jan; 103(1):1-14. PubMed ID: 30466666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a dark side to long-term proton pump inhibitor therapy?
    Nealis TB; Howden CW
    Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adverse effects of long-term proton-pump inhibitor therapy on adults].
    Igaz I; Simonyi G; Balogh S; Szathmári M
    Orv Hetil; 2018 May; 159(19):735-740. PubMed ID: 29730946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When proton pump inhibitors fail.
    Kahrilas PJ
    Clin Gastroenterol Hepatol; 2008 May; 6(5):482-3. PubMed ID: 18378500
    [No Abstract]   [Full Text] [Related]  

  • 36. What are the risks of long-term PPI use for GERD symptoms in patients > 65 years?
    Devitt J; Lyon C; Swanson SB; DeSanto K
    J Fam Pract; 2019 Apr; 68(3):E18-E19. PubMed ID: 31039222
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term use of proton pump inhibitors--really harmless?].
    Haag S
    Dtsch Med Wochenschr; 2014 Feb; 139(7):343. PubMed ID: 24496898
    [No Abstract]   [Full Text] [Related]  

  • 38. [Long-term use of proton pump inhibitors--really harmless?].
    Pommer P
    Dtsch Med Wochenschr; 2014 Feb; 139(7):343. PubMed ID: 24496897
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".
    Ghebremariam YT; Lee JC; LePendu P; Erlanson DA; Slaviero A; Shah NH; Leiper JM; Cooke JP
    Circulation; 2014 Apr; 129(13):e428. PubMed ID: 24687654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.